[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update #1: Tokyo 2020 and Infectious Diseases – The Challenge of AMR (November 6, 2019)
date : 12/12/2019
Tags: AMR, Diet Member Briefing
![[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update #1: Tokyo 2020 and Infectious Diseases – The Challenge of AMR (November 6, 2019)](https://hgpi.org/en/wp-content/uploads/sites/2/dmb-20191106-top.jpeg)
HGPI held its first “30-minute Health Policy Update,” a new series of briefings for Diet Members about the most pressing health policy issues today. This first meeting covered the topic of “Tokyo 2020 and Infectious Diseases – The Challenge of AMR.”
Dr. Kazuhiro Tateda (President of the Japanese Association for Infectious Diseases / President, The Japanese Society for Clinical Microbiology / Professor, Department of Microbiology and Infectious Diseases, Toho University) presented on the current need for policies on antimicrobial resistance (AMR). Afterward, there was a question and answer session with the gathered Diet Members.
■Background
Every year, Antimicrobial Resistance (AMR) leads to the death of as many as 700,000 people around the world. In Japan, AMR is becoming an issue for many medical facilities, and cases of community-acquired drug-resistant infections on the rise nationally. Japan enacted a National Action Plan on Antimicrobial Resistance in April 2016, and has been promoting AMR-related measures ever since. Sensing growing concern about AMR domestically and abroad, HGPI has been pursuing policy action on this topic since 2016. In November 2018, HGPI partnered with academic societies working in infectious disease medicine, pharmaceutical companies, and medical device makers, to establish AMR Alliance Japan, an independent platform for the promotion of multisector discussion on AMR countermeasures. More information about AMR Alliance Japan can be found at the official website.
■Program
Welcoming Remarks
Hanako Jimi (Member of the House of Councillors)
Explanatory Introduction
Shunichiro Kurita (Senior Associate, HGPI)
Presentation “Tokyo 2020 and Infectious Diseases – The Challenge of AMR”
Kazuhiro Tateda (President of the Japanese Association for Infectious Diseases/President, The Japanese Society for Clinical Microbiology/Professor, Department of Microbiology and Infectious Diseases, Toho University)
Closing Remarks
Kiyoshi Kurokawa (Chairman, HGPI)
Top Research & Recommendations Posts
- [Policy Recommendation] Preparing for “Disaster-Level Heat” in the 2025 Basic Policy on Economic and Fiscal Management and Reform (June 9, 2025)
- [Event Report] Round Table Discussion “Understanding Menopausal Women’s Health as a Social Issue” (November 19, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendation] Integrating “Planetary Health” as a Growth Strategy — Proposal for the Grand Design and Action Plan for a New Form of Capitalism (2025 Revised Edition) (June 9, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)
- [Policy Recommendations] HGPI Joint Input to the Zero Draft Political Declaration on NCDs and Mental Health (May 23, 2025)
Featured Posts
-
2025-07-04
[Registration Open] (Webinar) The 136th HGPI Seminar “Where We Are Now and Where We Are Going Regarding PPI in Mental Health Research: Learning from the TOGETHER Project in the Form of Co-Creation” (July 28, 2025)
-
2025-07-04
[Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)
-
2025-07-08
[Registration Open] Planetary Health Academy (Starts August 2025)
-
2025-07-14
[Policy Recommendation] Ensuring Equitable Access to Cancer Gene Panel Testing and Key Considerations for Applying the Mixed Medical Services Program (April 28, 2025)
-
2025-07-16
[Event Report] 1st Chair’s Dialogue “Introduction to Public-Private Partnerships – Global Case Studies in the Healthcare Sector” (May 9, 2025)